SECTOR ANALYSIS

Bispecific Antibody Oncology Biotech Companies

Grades, scores, and FDA catalyst signals for Bispecific Antibody Oncology stocks tracked by BiotechSign

← Full ScreenerFDA CalendarAll Sectors
Companies
36
Avg Score
60
Top Grade
A
Grade A
4
Bispecific Antibody Oncology Companies36 tracked
TickerCompanyScoreGradeSectorSignals
DCPHDeciphera Pharmaceuticals91AOncology
BGNEBeiGene Ltd88AOncology
KPTIKaryopharm Therapeutics87AOncology
BPMCBlueprint Medicines82AOncology
ITOSiTeos Therapeutics76BOncology
MGNXMacroGenics Inc75BOncology
INCYIncyte Corporation69BOncology
EXELExelixis Inc68BOncology
ONCYOncolytics Biotech, Inc.65BOncology
NUVBNuvation Bio63COncology
CATXPerspective Therapeutics62COncology
BCABBioAtla Inc62COncology
CDTXCidara Therapeutics61COncology
ALXOALX Oncology61COncology
TGTXTG Therapeutics61COncology
KURAKura Oncology, Inc.60COncology
CELCCelcuity Inc59COncology
FUSNFusion Pharmaceuticals59COncology
LTRNLantern Pharma58COncology
SNDXSyndax Pharmaceuticals58COncology
GERNGeron Corporation55COncology
ERASErasca Inc55COncology
IMGNImmunoGen Inc53COncology
LBPHLongboard Pharmaceuticals53COncology
GTHXG1 Therapeutics53COncology
TOIThe Oncology Institute, Inc.49DOncology
ZNTLZentalis Pharmaceuticals49DOncology
BPTHBio-Path Holdings48DOncology
RAPTRAPT Therapeutics48DOncology
LPTXLeap Therapeutics47DOncology
CGONCG Oncology, Inc.46DOncology
CRDFCardiff Oncology, Inc.46DOncology
CRVSCorvus Pharmaceuticals46DOncology
CTORCitius Oncology, Inc.44DOncology
ALLRAllarity Therapeutics43DOncology
ARAVAravive Inc43DOncology
Not financial advice. All data and analysis provided by Guerilla Finance Inc. BiotechSign grades and scores are algorithmic signals only and do not constitute investment recommendations. Biotech investing involves significant risk, including the potential for complete loss of capital on binary FDA events. Always conduct your own due diligence before making investment decisions.